Authors:
Madroszyk, A
Egreteau, J
Martin, L
Queneau, PE
Bosset, JF
Merrouche, Y
Citation: A. Madroszyk et al., Small-cell carcinoma of the esophagus: Report of three cases and review ofthe literature with emphasis on therapy, ANN ONCOL, 12(9), 2001, pp. 1321-1325
Authors:
Bosset, JF
Horiot, JC
Hamers, HP
Cionini, L
Bartelink, H
Caspers, R
Untereiner, A
Ciambelloti, E
Pierart, M
Van Glabbeke, A
Citation: Jf. Bosset et al., Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group, RADIOTH ONC, 61(1), 2001, pp. 7-13
Authors:
Bosset, JF
Magnin, V
Maingon, P
Mantion, G
Pelissier, EP
Mercier, M
Chaillard, G
Horiot, JC
Citation: Jf. Bosset et al., Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial, INT J RAD O, 46(2), 2000, pp. 323-327
Authors:
Mennecier, B
Jacoulet, P
Dubiez, A
Westeel, V
Bosset, JF
Magnin, V
Depierre, A
Citation: B. Mennecier et al., Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study, LUNG CANC, 27(3), 2000, pp. 137-143
Authors:
Wang, Q
Lasset, C
Desseigne, F
Saurin, JC
Maugard, C
Navarro, C
Ruano, E
Descos, L
Trillet-Lenoir, V
Bosset, JF
Puisieux, A
Citation: Q. Wang et al., Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer, HUM GENET, 105(1-2), 1999, pp. 79-85
Citation: Jf. Bosset et M. Marty, Clinical evaluation of and practical recommendations far concomitant chemoradiation, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 75-77
Citation: Jf. Bosset et P. Maingon, Adjuvant chemoradiation for rectal cancer, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 149-155